Mkh. Schafer et al., Complement C1q is dramatically up-regulated in brain microglia in responseto transient global cerebral ischemia, J IMMUNOL, 164(10), 2000, pp. 5446-5452
Recent evidence suggests that the pathophysiology of neurodegenerative and
inflammatory neurological diseases has a neuroimmunological component invol
ving complement, an innate humoral immune defense system. The present study
demonstrates the effects of experimentally induced global ischemia on the
biosynthesis of Clq, the recognition subcomponent of the classical compleme
nt activation pathway, in the CNS. Using semiquantitative in situ hybridiza
tion, immunohistochemistry, and confocal laser scanning microscopy, a drama
tic and widespread increase of Clq biosynthesis in rat brain microglia (but
not in astrocytes or neurons) within 24 h after the ischemic insult was ob
served, A marked increase of Clq functional activity in cerebrospinal fluid
taken 1, 24, and 72 h after the ischemic insult was determined by Clq-depe
ndent hemolytic assay. In the light of the well-established role of complem
ent and complement activation products in the initiation and maintenance of
inflammation, the ischemia-induced increase of cerebral Clq biosynthesis a
nd of Clq functional activity in the cerebrospinal fluid implies that the p
roinflammatory activities of locally produced complement are likely to cont
ribute to the pathophysiology of cerebral ischemia, Pharmacological modulat
ion of complement activation in the brain may be a therapeutic target in th
e treatment of stroke.